YME1L1 and central nervous system cancer: To confirm the significance of the bioinformatics observations, we tested YME1L expression in local human glioma tissues (“T”) and surrounding normal brain (“N”) tissues, from a total of 16 grade III–IV glioma (HGG) patients (see our previous studies such as Liu et al. (2018) and Wang et al. (2021).